Nutanix’s (NTNX) Buy Rating Reaffirmed at Needham & Company LLC

Needham & Company LLC reissued their buy rating on shares of Nutanix (NASDAQ:NTNX – Free Report) in a research report report published on Thursday morning,Benzinga reports. The firm currently has a $92.00 target price on the technology company’s stock. Other analysts have also issued reports about the company. UBS Group raised their price objective on […]

Leave a Reply

Your email address will not be published.

Previous post HCA Healthcare (NYSE:HCA) Upgraded to “Equal Weight” at Wells Fargo & Company
Next post Tenet Healthcare (NYSE:THC) Upgraded to “Overweight” at Wells Fargo & Company